GO:0014033 neural crest cell differentiation: Lineage Specification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014033 neural crest cell differentiation describes the process by which a relatively unspecialized cell acquires the specialized features of a neural crest cell.
• Neural crest cells are transient, multipotent embryonic cells that undergo epithelial-to-mesenchymal transition (EMT), migrate extensively, and differentiate into diverse derivatives including neurons, glia, melanocytes, chondrocytes, osteocytes, and odontoblasts.
• Lineage diversification is orchestrated by spatiotemporally regulated transcription factor networks and signaling pathways, as revealed by single-cell regulatory atlases.
• Key transcription factors such as SOX10, PAX3, FOXD3, SNAI1/2, TWIST1, and TFAP2A, together with signaling inputs from WNT, BMP, FGF, and NOTCH, control neural crest specification and differentiation.
• Defects in neural crest cell differentiation underlie numerous human diseases, including neurocristopathies, melanoma, and developmental anomalies of the craniofacial skeleton, heart, and enteric nervous system.
• Modern research employs single-cell RNA sequencing, lineage tracing, quantitative migration assays, and CRISPR-based genome editing to dissect neural crest differentiation mechanisms.
Description
Neural crest cells are a vertebrate-specific population of multipotent progenitors that arise at the neural plate border during gastrulation and subsequently delaminate, migrate, and differentiate into a remarkable array of cell types. The Gene Ontology term GO:0014033, neural crest cell differentiation, captures the developmental process in which a relatively unspecialized cell acquires the specialized features of a neural crest cell. This process is fundamental to embryonic development and tissue morphogenesis, as neural crest derivatives contribute to the peripheral nervous system, craniofacial skeleton, melanocytes, and cardiac outflow tract. Understanding neural crest cell differentiation is therefore critical for developmental biology, regenerative medicine, and the study of neurocristopathies and cancer. Research over the past decades has elucidated that neural crest cell differentiation is not a single event but a progressive, multi-step process involving induction, specification, EMT, migration, and terminal differentiation. Each step is governed by combinatorial transcription factor codes and extracellular signals that vary by axial level and developmental time. The advent of single-cell technologies and advanced imaging has provided unprecedented resolution of the gene regulatory networks and cellular dynamics underlying this process. Consequently, GO:0014033 serves as a central annotation for genes and pathways that orchestrate neural crest development, and its dysregulation is linked to a broad spectrum of congenital and acquired diseases.
neural crest cell differentiation At A Glance
| GO ID | GO:0014033 |
|---|---|
| GO term | neural crest cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Acquisition of specialized features of a neural crest cell from a relatively unspecialized cell |
| Related processes | Neural crest cell migration, epithelial-to-mesenchymal transition, lineage specification |
| Key regulators | SOX10, PAX3, FOXD3, SNAI1/2, TWIST1, TFAP2A, WNT, BMP, FGF, NOTCH signaling |
| Disease relevance | Neurocristopathies, melanoma, craniofacial anomalies, Hirschsprung disease |
| Research methods | Single-cell RNA-seq, lineage tracing, quantitative migration assays, CRISPR screens |
What Is GO:0014033?
GO:0014033 neural crest cell differentiation is defined as the biological process in which a relatively unspecialized cell acquires the specialized features of a neural crest cell. This encompasses the molecular and cellular changes that commit a progenitor cell to the neural crest lineage and endow it with characteristic properties such as multipotency, migratory capacity, and the ability to differentiate into diverse derivatives. The term is a child of broader developmental processes and is distinct from neural crest cell migration and neural crest cell proliferation, although these processes are tightly coordinated during embryogenesis.
Why Is neural crest cell differentiation Important in Cell Biology?
Neural crest cell differentiation is a cornerstone of vertebrate embryogenesis because neural crest derivatives are essential for the formation of the peripheral nervous system, craniofacial skeleton, melanocytes, and cardiac septa. Disruptions in this process lead to severe congenital disorders collectively known as neurocristopathies, as well as cancers such as melanoma. Moreover, understanding how multipotent neural crest cells choose their fates provides a paradigm for studying stem cell differentiation and holds promise for regenerative medicine. Therefore, GO:0014033 is a critical annotation for researchers investigating developmental biology, disease mechanisms, and potential therapeutic interventions.
• Neural crest cell differentiation is essential for the formation of diverse tissues and organs, including the peripheral nervous system, craniofacial cartilage and bone, melanocytes, and the enteric nervous system.
• Defects in neural crest cell differentiation cause neurocristopathies such as Waardenburg syndrome, Hirschsprung disease, and CHARGE syndrome.
• Melanoma, a highly aggressive cancer, arises from melanocytes that are neural crest derivatives, and its progression is linked to dysregulated neural crest differentiation programs.
• Single-cell regulatory atlases have revealed spatiotemporal dynamics of neural crest lineage diversification, providing a resource for understanding tooth morphogenesis and other developmental processes.
• Quantitative analysis of neural crest cell migration is crucial for understanding how differentiation is coordinated with movement to target tissues.
• The epithelial-to-mesenchymal transition (EMT) is a key step in neural crest cell differentiation, and its regulation is relevant to both development and cancer metastasis.
• Evolutionary studies of neural crest cell differentiation into cartilage and bone shed light on the origin of the vertebrate skeleton.
• Plasticity in neural crest cell differentiation allows environmental signals to influence fate choices, which has implications for stem cell biology and tissue engineering.
• CRISPR-based genome editing enables functional dissection of genes involved in neural crest cell differentiation, accelerating the discovery of disease mechanisms.
• Understanding neural crest cell differentiation informs strategies for directing pluripotent stem cells toward clinically relevant neural crest derivatives.
What Happens During neural crest cell differentiation?
Induction and Specification of the Neural Crest
In simple terms: This is when embryonic cells at the border of the future nervous system are told to become neural crest cells.
Neural crest induction occurs at the neural plate border, where a combination of WNT, BMP, and FGF signals from surrounding tissues activates a cascade of transcription factors including PAX3, ZIC1, MSX1/2, and TFAP2A. These factors establish the neural crest gene regulatory network and specify the neural crest territory. Single-cell regulatory atlases have revealed that this specification is a dynamic process with spatiotemporal heterogeneity, as shown during tooth morphogenesis where neural crest lineage diversification is precisely orchestrated. The induction phase is characterized by the expression of early neural crest markers such as FOXD3 and SNAI2, which reinforce the neural crest identity and prepare cells for subsequent steps.
Epithelial-to-Mesenchymal Transition (EMT) and Delamination
In simple terms: Neural crest cells change from being tightly packed in a sheet to becoming loose, migratory cells.
Following specification, neural crest cells undergo an epithelial-to-mesenchymal transition (EMT), a process that involves the downregulation of cell adhesion molecules like E-cadherin and the upregulation of mesenchymal markers such as N-cadherin and vimentin. This transition is driven by transcription factors including SNAI1, SNAI2, TWIST1, and FOXD3, which repress epithelial genes and activate migratory machinery. EMT enables neural crest cells to delaminate from the neural tube and begin migration. The timing and regulation of EMT are critical, as highlighted by studies showing that neural crest cells must coordinate EMT with cell cycle progression to exit the neuroepithelium properly.
Migration and Patterning
In simple terms: Neural crest cells travel along defined routes to reach their final destinations in the embryo.
After delamination, neural crest cells migrate along stereotypical pathways throughout the embryo, guided by attractive and repulsive cues such as chemokines, extracellular matrix components, and contact-mediated signals. Migration is highly directional and can be quantitatively analyzed using advanced imaging and computational methods. During migration, neural crest cells remain multipotent but begin to respond to local environmental signals that influence their subsequent differentiation. For example, single-cell studies during tooth morphogenesis have shown that neural crest cells diversify into distinct lineages as they populate the developing tooth, reflecting spatiotemporal regulatory dynamics.
Lineage Diversification and Terminal Differentiation
In simple terms: Once they reach their targets, neural crest cells specialize into many different cell types like neurons, pigment cells, and bone.
Neural crest cells differentiate into a wide variety of derivatives, including sensory and autonomic neurons, glial cells, melanocytes, chondrocytes, osteocytes, odontoblasts, and smooth muscle cells. This lineage diversification is controlled by combinatorial transcription factor networks that are activated in response to local signals. For instance, SOX10 is essential for melanocyte and glial differentiation, while RUNX2 and OSTERIX drive osteogenic differentiation of cranial neural crest cells. The differentiation into cartilage and bone has been extensively studied from an evolutionary perspective, revealing conserved and divergent mechanisms across vertebrates. Melanocyte lineage dynamics, from development to disease, further illustrate the complexity of terminal differentiation programs.
Plasticity and Environmental Influence
In simple terms: Neural crest cells can change their fate depending on the signals they receive, showing remarkable flexibility.
Neural crest cells exhibit significant plasticity, meaning their differentiation outcomes can be influenced by environmental cues and experimental manipulation. Classic studies have demonstrated that neural crest cells can adopt alternative fates when transplanted to different regions or exposed to specific growth factors. This plasticity is mediated by the interplay of transcription factors and epigenetic regulators that maintain multipotency while allowing lineage-specific gene activation. Understanding this plasticity is important for regenerative medicine, as it suggests that neural crest cells or their derivatives could be directed toward desired cell types for therapeutic purposes.
Key Genes Involved in GO:0014033 neural crest cell differentiation
The following genes and proteins are central to neural crest cell differentiation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX10 | Master regulator of neural crest specification, melanocyte and glial differentiation | Mutations cause Waardenburg syndrome; key marker for neural crest lineages |
| PAX3 | Early neural crest induction and specification | Associated with Waardenburg syndrome and craniofacial anomalies |
| FOXD3 | Maintains neural crest progenitor state and regulates EMT | Critical for multipotency and prevention of premature differentiation |
| SNAI1 | Induces EMT and represses E-cadherin | Essential for neural crest delamination and migration |
| SNAI2 | Promotes EMT and survival of neural crest cells | Linked to Waardenburg syndrome and melanoma progression |
| TWIST1 | Regulates EMT and migration | Mutations cause Saethre-Chotzen syndrome; involved in craniofacial development |
| TFAP2A | Neural crest specification and differentiation | Mutations cause branchio-oculo-facial syndrome |
| ZIC1 | Neural plate border specification | Cooperates with PAX3 in neural crest induction |
| MSX1 | Neural crest patterning and craniofacial development | Associated with cleft palate and tooth agenesis |
| RUNX2 | Osteogenic differentiation of cranial neural crest cells | Mutations cause cleidocranial dysplasia |
| SP7 (OSTERIX) | Bone formation by neural crest-derived osteoblasts | Key regulator of craniofacial bone development |
| MITF | Melanocyte differentiation and pigmentation | Mutations cause Waardenburg syndrome type 2; melanoma oncogene |
| EDNRB | Migration and differentiation of enteric neural crest cells | Mutations cause Hirschsprung disease |
| RET | Enteric nervous system development | Mutations cause Hirschsprung disease and MEN2 |
| PHOX2B | Autonomic nervous system differentiation | Mutations cause congenital central hypoventilation syndrome |
| BMP4 | Signaling that influences neural crest differentiation | Involved in craniofacial and cardiac neural crest development |
| WNT1 | Promotes neural crest induction and melanocyte differentiation | Mutations cause osteogenesis imperfecta and Waardenburg syndrome |
How Is neural crest cell differentiation Regulated?
Neural crest cell differentiation is regulated by a complex interplay of extracellular signals and intracellular transcriptional networks. Key signaling pathways include WNT, BMP, FGF, and NOTCH, which provide spatial and temporal cues that modulate the activity of core neural crest transcription factors such as SOX10, PAX3, FOXD3, and TFAP2A. For example, WNT signaling promotes neural crest induction and melanocyte differentiation, while BMP signaling can either promote or inhibit differentiation depending on context and timing. Additionally, epigenetic regulators and microRNAs fine-tune gene expression programs during differentiation. The epithelial-to-mesenchymal transition (EMT) is a critical regulatory node, controlled by SNAI1/2, TWIST1, and FOXD3, which integrate signals to coordinate delamination with differentiation. Quantitative analysis of migration has revealed that guidance cues also influence differentiation by determining when and where neural crest cells stop migrating and initiate terminal differentiation programs. Single-cell regulatory atlases have further uncovered spatiotemporal gene regulatory networks that drive lineage diversification, highlighting the dynamic nature of this regulation.
neural crest cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOX10 | Waardenburg syndrome, melanoma | Knockout or point-mutation in human iPSCs followed by melanocyte differentiation |
| MITF | Waardenburg syndrome type 2, melanoma | Knock-in of patient mutations in melanoma cell lines or iPSCs |
| RET | Hirschsprung disease | Knockout in mouse models or human enteric neural crest cells |
| EDNRB | Hirschsprung disease | Point-mutation knock-in in zebrafish or mouse |
| RUNX2 | Cleidocranial dysplasia | Knockout in cranial neural crest cells derived from iPSCs |
Neurocristopathies: Developmental Disorders of Neural Crest Derivatives
Neurocristopathies are a diverse group of congenital disorders caused by defects in neural crest cell formation, migration, or differentiation. Examples include Waardenburg syndrome (pigmentary and hearing defects due to melanocyte deficiency), Hirschsprung disease (absence of enteric ganglia due to failure of enteric neural crest cell differentiation), and CHARGE syndrome (craniofacial and cardiac anomalies). Mutations in genes such as SOX10, PAX3, MITF, EDNRB, and RET have been identified in these conditions, underscoring the importance of proper neural crest differentiation for human development. Research using animal models and patient-derived cells has elucidated how these mutations disrupt specific differentiation steps, providing insights for potential therapies.
Melanoma: Cancer of Neural Crest-Derived Melanocytes
Melanoma is an aggressive cancer that arises from melanocytes, which are neural crest derivatives. The differentiation state of melanoma cells is closely linked to their malignant properties, with dedifferentiated cells exhibiting increased invasiveness and therapy resistance. Key neural crest transcription factors such as MITF, SOX10, and PAX3 play dual roles in melanocyte development and melanoma progression. Understanding the mechanisms of neural crest differentiation has therefore direct implications for melanoma biology, including the identification of therapeutic targets and biomarkers.
Craniofacial and Skeletal Anomalies
Cranial neural crest cells give rise to the majority of the craniofacial skeleton, including cartilage and bone. Defects in their differentiation lead to craniofacial anomalies such as cleft palate, micrognathia, and craniosynostosis. Studies on the development, patterning, and evolution of neural crest cell differentiation into cartilage and bone have identified critical genes like RUNX2, SP7, and MSX1, mutations in which cause human skeletal disorders. These findings highlight the clinical relevance of understanding neural crest differentiation for diagnosing and potentially treating craniofacial birth defects.
Enteric Nervous System Disorders
The enteric nervous system is derived from neural crest cells that migrate to the gut and differentiate into neurons and glia. Failure of this process results in Hirschsprung disease, characterized by the absence of enteric ganglia in distal colon segments. Genes such as RET, EDNRB, and SOX10 are critical for enteric neural crest cell differentiation, and their mutations are associated with Hirschsprung disease. Research on neural crest differentiation in the gut continues to inform our understanding of this common congenital disorder.
From neural crest cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair neural crest differentiation? | CRISPR knockout in human embryonic stem cells or iPSCs followed by directed differentiation |
| Does a specific point mutation found in patients alter neural crest lineage specification? | CRISPR point-mutation knock-in in iPSCs or cell lines |
| Can a reporter gene track neural crest differentiation in real time? | Knock-in of fluorescent reporter (e.g., SOX10-GFP) using CRISPR |
| What is the effect of overexpressing a transcription factor on neural crest fate? | CRISPR-mediated overexpression (e.g., via safe-harbor locus) in progenitor cells |
| Which genes are essential for neural crest migration and differentiation? | Genome-wide CRISPR library screening in migratory neural crest cells |
| How does a disease-associated variant affect neural crest differentiation at single-cell resolution? | Single-cell RNA-seq combined with CRISPR editing in differentiation cultures |
How to Study the neural crest cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Gene expression profiles of individual cells | Mapping neural crest lineage diversification and differentiation trajectories |
| Quantitative migration assay | Directionality, speed, and persistence of cell movement | Studying neural crest cell migration and its coordination with differentiation |
| Lineage tracing | Fate of neural crest cells and their progeny | Determining contributions of neural crest to tissues and organs |
| CRISPR knockout screening | Genes essential for neural crest differentiation | Identifying novel regulators and disease genes |
| Immunofluorescence | Protein expression and localization | Validating differentiation markers and transcription factor expression |
| RNA-seq | Transcriptome changes during differentiation | Comparing wild-type and mutant neural crest cells |
| ChIP-seq | Transcription factor binding sites | Mapping regulatory networks controlling neural crest differentiation |
| Live imaging | Cellular dynamics during EMT and migration | Visualizing neural crest delamination and migration in real time |
Single-Cell Transcriptomics for Lineage Diversification
Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of neural crest cell differentiation by allowing researchers to profile gene expression in thousands of individual cells at multiple developmental time points. This approach has been used to construct spatiotemporal regulatory atlases of neural crest lineage diversification, revealing distinct cell states and differentiation trajectories. For example, during tooth morphogenesis, scRNA-seq uncovered the regulatory dynamics of neural crest cells as they differentiate into odontoblasts and other lineages. Such atlases provide a valuable resource for identifying novel markers and gene regulatory networks involved in neural crest differentiation.
Quantitative Migration Assays
Neural crest cell migration is a key step that precedes terminal differentiation, and quantitative analysis of migration is essential for understanding how differentiation is coordinated with movement. Methods such as time-lapse imaging, chemotaxis assays, and computational tracking allow researchers to measure directionality, speed, and persistence of neural crest cell migration. These techniques can be combined with genetic perturbations to assess the role of specific genes in migration and subsequent differentiation.
Lineage Tracing and Genetic Fate Mapping
Lineage tracing using Cre-lox or CRISPR-based barcoding enables researchers to follow the fate of neural crest cells from their origin to their differentiated derivatives. This approach has been instrumental in demonstrating the plasticity of neural crest cells and their contribution to diverse tissues. Genetic fate mapping in model organisms such as mice and zebrafish has provided insights into the developmental origins of neural crest derivatives and the genes that control their differentiation.
CRISPR Screens for Functional Genomics
CRISPR-based loss-of-function screens have emerged as powerful tools to systematically identify genes required for neural crest cell differentiation. By introducing genome-wide guide RNA libraries into neural crest progenitor cells and inducing differentiation, researchers can uncover novel regulators and pathways. Such screens can be combined with single-cell readouts to link genotype to phenotype at scale. These functional genomics approaches accelerate the discovery of genes involved in neurocristopathies and cancer.
How CRISPR Can Be Used to Study GO:0014033 neural crest cell differentiation
Knockout
CRISPR knockout is widely used to study neural crest cell differentiation by disrupting candidate genes in pluripotent stem cells or neural crest progenitors. For example, knockout of SOX10 or MITF in human iPSCs followed by directed differentiation can reveal their essential roles in melanocyte specification. Genome-wide knockout screens have identified numerous genes required for neural crest differentiation, including those involved in EMT and migration. Knockout models are invaluable for establishing causality between gene function and differentiation phenotypes.
Point Mutation
Point mutations identified in patients with neurocristopathies can be introduced into cell lines or iPSCs using CRISPR base editing or homology-directed repair to model disease-specific effects on neural crest differentiation. For instance, knock-in of Waardenburg syndrome-associated mutations in PAX3 or SOX10 allows researchers to study how these subtle changes alter differentiation trajectories. Such models are crucial for understanding genotype-phenotype relationships and for testing potential therapeutic interventions.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins, into endogenous loci (e.g., SOX10, TFAP2A) enables real-time monitoring of neural crest differentiation in vitro and in vivo. Additionally, knock-in of epitope tags facilitates chromatin immunoprecipitation and proteomic studies to dissect regulatory complexes. CRISPR knock-in can also be used to overexpress wild-type or mutant cDNAs from a safe-harbor locus to assess their effects on differentiation.
Overexpression
CRISPR activation (CRISPRa) or knock-in of inducible expression cassettes allows researchers to overexpress transcription factors or signaling molecules to drive or perturb neural crest differentiation. For example, overexpression of FOXD3 or SNAI2 can maintain progenitor state or promote EMT, respectively. Overexpression models are useful for gain-of-function studies and for directing differentiation of stem cells toward specific neural crest derivatives for regenerative medicine.
How EDITGENE Supports neural crest cell differentiation Research
Researchers studying neural crest cell differentiation-related genes often need to determine whether a candidate gene is causally involved in lineage specification, EMT, migration, or terminal differentiation. Establishing such causal links requires precise genetic manipulation in relevant cell models, followed by functional assays. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout and point mutation to knock-in and overexpression, as well as high-throughput library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for neural crest cell differentiation research.
Frequently Asked Questions About neural crest cell differentiation
What is neural crest cell differentiation?
Neural crest cell differentiation is the biological process in which a relatively unspecialized cell acquires the specialized features of a neural crest cell, as defined by GO:0014033. It involves induction, specification, epithelial-to-mesenchymal transition, migration, and terminal differentiation into diverse cell types.
What genes are involved in neural crest cell differentiation?
Key genes include SOX10, PAX3, FOXD3, SNAI1/2, TWIST1, TFAP2A, MITF, and signaling pathway components such as WNT1, BMP4, and RET. These genes regulate various stages from induction to terminal differentiation.
What diseases are associated with defects in neural crest cell differentiation?
Defects cause neurocristopathies such as Waardenburg syndrome, Hirschsprung disease, CHARGE syndrome, and craniofacial anomalies, as well as melanoma. Each disease is linked to specific gene mutations affecting neural crest development.
How is neural crest cell differentiation studied in the lab?
Researchers use single-cell RNA sequencing, lineage tracing, quantitative migration assays, and CRISPR-based genome editing to study neural crest differentiation. These methods allow detailed analysis of gene function and cellular dynamics.
What is the role of SOX10 in neural crest cell differentiation?
SOX10 is a master regulator of neural crest specification and is essential for melanocyte and glial differentiation. Mutations in SOX10 cause Waardenburg syndrome and are studied in melanoma.
How does epithelial-to-mesenchymal transition (EMT) relate to neural crest cell differentiation?
EMT is a critical step in neural crest cell differentiation that enables delamination and migration from the neural tube. It is driven by transcription factors such as SNAI1, SNAI2, and TWIST1.
Can CRISPR be used to study neural crest cell differentiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in neural crest differentiation. CRISPR screens can identify novel regulators.
What are neural crest derivatives?
Neural crest derivatives include neurons and glia of the peripheral nervous system, melanocytes, craniofacial cartilage and bone, odontoblasts, and enteric ganglia. These diverse cell types arise through differentiation programs.
What is the significance of neural crest cell plasticity?
Neural crest cells exhibit remarkable plasticity, meaning their differentiation fate can be influenced by environmental signals. This plasticity is important for understanding development and for regenerative medicine applications.
How does single-cell RNA sequencing help study neural crest differentiation?
Single-cell RNA sequencing provides a high-resolution view of gene expression changes during neural crest differentiation, revealing lineage trajectories and regulatory networks. It has been used to construct spatiotemporal atlases of neural crest diversification.
Conclusion
GO:0014033 neural crest cell differentiation is a fundamental developmental process that governs the formation of diverse cell types and tissues in vertebrates. Its dysregulation leads to a range of congenital disorders and cancers, making it a critical area of research. Advances in single-cell technologies, quantitative imaging, and CRISPR-based genome editing continue to unravel the complex regulatory networks underlying this process. Understanding neural crest cell differentiation not only sheds light on embryonic development but also offers potential avenues for regenerative medicine and targeted therapies.
References
- 1. Jing J et al.. 2022. Spatiotemporal single-cell regulatory atlas reveals neural crest lineage diversification and cellular function during tooth morphogenesis.. Nat Commun 13(1):4803 PMID: 35974052
- 2. Kyriakoudi SA et al.. 2024. Genetic Identity of Neural Crest Cell Differentiation in Tissue and Organ Development.. Front Biosci (Landmark Ed) 29(7):261 PMID: 39082344
- 3. Le Douarin NM et al.. 1993. Plasticity in neural crest cell differentiation.. Curr Opin Cell Biol 5(6):1036-43 PMID: 8129941
- 4. Dash S et al.. 2020. The development, patterning and evolution of neural crest cell differentiation into cartilage and bone.. Bone 137:115409 PMID: 32417535
- 5. Bhatt S et al.. 2013. Signals and switches in Mammalian neural crest cell differentiation.. Cold Spring Harb Perspect Biol 5(2) PMID: 23378583
- 6. Nie S. 2022. Quantitative Analysis of Directional Neural Crest Cell Migration.. Methods Mol Biol 2438:517-526 PMID: 35147961
- 7. Leathers TA et al.. 2022. Time to go: neural crest cell epithelial-to-mesenchymal transition.. Development 149(15) PMID: 35905012
- 8. Brombin A et al.. 2024. Melanocyte lineage dynamics in development, growth and disease.. Development 151(15) PMID: 39092608
